Hereditary transthyretin amyloid neuropathies: advances in pathophysiology, biomarkers, and treatment
出版年份 2023 全文链接
标题
Hereditary transthyretin amyloid neuropathies: advances in pathophysiology, biomarkers, and treatment
作者
关键词
-
出版物
LANCET NEUROLOGY
Volume 22, Issue 11, Pages 1061-1074
出版商
Elsevier BV
发表日期
2023-10-19
DOI
10.1016/s1474-4422(23)00334-4
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Corneal confocal microscopy identifies corneal nerve loss and increased Langerhans cells in presymptomatic carriers and patients with hereditary transthyretin amyloidosis
- (2023) Andreas Thimm et al. JOURNAL OF NEUROLOGY
- Phase 1 Trial of Antibody NI006 for Depletion of Cardiac Transthyretin Amyloid
- (2023) Pablo Garcia-Pavia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Skin amyloid deposits and nerve fiber loss as markers of neuropathy onset and progression in hereditary transthyretin amyloidosis
- (2022) Luca Leonardi et al. EUROPEAN JOURNAL OF NEUROLOGY
- Elderly patients with suspected Charcot-Marie-Tooth disease should be tested for the TTR gene for effective treatments
- (2022) Takaki Taniguchi et al. JOURNAL OF HUMAN GENETICS
- Clinical and Genetic Evaluation of People with or at Risk of Hereditary ATTR Amyloidosis: An Expert Opinion and Consensus on Best Practice in Ireland and the UK
- (2022) Julian D. Gillmore et al. ADVANCES IN THERAPY
- Patisiran treatment in patients with hereditary transthyretin‐mediated amyloidosis with polyneuropathy after liver transplantation
- (2022) Hartmut H. Schmidt et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Characteristics of patients with autonomic dysfunction in the Transthyretin Amyloidosis Outcomes Survey (THAOS)
- (2022) Fabio A. Barroso et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- Guidelines and new directions in the therapy and monitoring of ATTRv amyloidosis
- (2022) Yukio Ando et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- CSF/plasma levels, transthyretin stabilisation and safety of multiple doses of tolcapone in subjects with hereditary ATTR amyloidosis
- (2022) Yusuke Takahashi et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- Real‐life experience with inotersen in hereditary transthyretin amyloidosis with late‐onset phenotype: Data from an early‐access program in Italy
- (2022) Marco Luigetti et al. EUROPEAN JOURNAL OF NEUROLOGY
- Expanding RNAi therapeutics to extrahepatic tissues with lipophilic conjugates
- (2022) Kirk M. Brown et al. NATURE BIOTECHNOLOGY
- A natural history analysis of asymptomatic TTR gene carriers as they develop symptomatic transthyretin amyloidosis in the Transthyretin Amyloidosis Outcomes Survey (THAOS)
- (2022) Teresa Coelho et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial
- (2022) David Adams et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- Long-term efficacy and safety of inotersen for hereditary transthyretin amyloidosis: NEURO-TTR open-label extension 3-year update
- (2022) Thomas H. Brannagan et al. JOURNAL OF NEUROLOGY
- Clinical and genetic profile of patients enrolled in the Transthyretin Amyloidosis Outcomes Survey (THAOS): 14-year update
- (2022) Angela Dispenzieri et al. Orphanet Journal of Rare Diseases
- Cutaneous amyloid is a biomarker in early ATTRv neuropathy and progresses across disease stages
- (2022) Roy Freeman et al. Annals of Clinical and Translational Neurology
- Neuropathology of central nervous system involvement in TTR amyloidosis
- (2022) Ricardo Taipa et al. ACTA NEUROPATHOLOGICA
- Predictors of cognitive dysfunction in hereditary transthyretin amyloidosis with liver transplant
- (2022) Sara Cavaco et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- Distribution and progression of cerebral amyloid angiopathy in early-onset V30M (p.V50M) hereditary ATTR amyloidosis
- (2022) Yusuke Takahashi et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- Toxic Misfolded Transthyretin Oligomers with Different Molecular Conformations Formed through Distinct Oligomerization Pathways
- (2022) Anvesh K. R. Dasari et al. BIOCHEMISTRY
- Feasibility Study of Dendrimer-Based TTR-CRISPR pDNA Polyplex for Ocular Amyloidosis <i>in Vitro</i>
- (2022) Masamichi Inoue et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Muscle quantitative MRI as a novel biomarker in hereditary transthyretin amyloidosis with polyneuropathy: a cross-sectional study
- (2022) Elisa Vegezzi et al. JOURNAL OF NEUROLOGY
- Ophthalmological involvement in patients with hereditary TTR amyloidosis
- (2022) Jorge Ruiz-Medrano et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Quantitative sensory testing: a good tool to identify subclinical neuropathy in ATTRV30M amyloidosis patients?
- (2022) Isabel Conceição et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- Beyond Val30Met transthyretin (TTR): variants associated with age-at-onset in hereditary ATTRv amyloidosis
- (2021) Miguel Alves-Ferreira et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- Canadian Guidelines for Hereditary Transthyretin Amyloidosis Polyneuropathy Management
- (2021) Monica Alcantara et al. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
- Feasibility of assessing progression of transthyretin amyloid polyneuropathy using nerve conduction studies: Findings from the Transthyretin Amyloidosis Outcomes Survey (THAOS)
- (2021) Márcia Waddington‐Cruz et al. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
- Progressive brachial plexus enlargement in hereditary transthyretin amyloidosis
- (2021) Alessandro Salvalaggio et al. JOURNAL OF NEUROLOGY
- Significance of Oligomeric and Fibrillar Species in Amyloidosis: Insights into Pathophysiology and Treatment
- (2021) Haruki Koike et al. MOLECULES
- CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
- (2021) Julian D. Gillmore et al. NEW ENGLAND JOURNAL OF MEDICINE
- A human antibody selective for transthyretin amyloid removes cardiac amyloid through phagocytic immune cells
- (2021) Aubin Michalon et al. Nature Communications
- Prevalence and Outcomes of p.Val142Ile TTR Amyloidosis Cardiomyopathy: A Systematic Review
- (2021) Pranav Chandrashekar et al. Circulation-Genomic and Precision Medicine
- Characteristics of Patients with Late- vs. Early-Onset Val30Met Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes Survey (THAOS)
- (2021) Márcia Waddington-Cruz et al. Neurology and Therapy
- Changes in nerve conduction studies predate clinical symptoms onset in early onset Val30Met hereditary ATTR amyloidosis
- (2021) José Castro et al. EUROPEAN JOURNAL OF NEUROLOGY
- Vagus nerve ultrasound in transthyretin familial amyloid polyneuropathy: A pilot study
- (2021) Kang Du et al. JOURNAL OF NEUROIMAGING
- High-resolution ultrasound of peripheral nerves in late-onset hereditary transthyretin amyloidosis with polyneuropathy: similarities and differences with CIDP
- (2021) Luca Leonardi et al. NEUROLOGICAL SCIENCES
- CNS Involvement in Hereditary Transthyretin Amyloidosis
- (2021) Luísa Sousa et al. NEUROLOGY
- Plasmin activity promotes amyloid deposition in a transgenic model of human transthyretin amyloidosis
- (2021) Ivana Slamova et al. Nature Communications
- Plasma neurofilament light chain: an early biomarker for hereditary ATTR amyloid polyneuropathy
- (2020) Luis F. Maia et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- Quality of life outcomes in APOLLO, the phase 3 trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis
- (2020) Laura Obici et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy
- (2020) David Adams et al. JOURNAL OF NEUROLOGY
- The frequency of central nervous system complications in the Cypriot cohort of ATTRV30M neuropathy transplanted patients
- (2020) Efthimios Dardiotis et al. NEUROLOGICAL SCIENCES
- Health-related quality of life in hereditary transthyretin amyloidosis polyneuropathy: a prospective, observational study
- (2020) Mónica Inês et al. Orphanet Journal of Rare Diseases
- TTR gene silencing therapy in post liver transplant hereditary ATTR amyloidosis patients
- (2020) Orly Moshe-Lilie et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- ATTRv amyloidosis Italian Registry: clinical and epidemiological data
- (2020) Massimo Russo et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- Monitoring of asymptomatic family members at risk of hereditary transthyretin amyloidosis for early intervention with disease-modifying therapies
- (2020) Mitsuharu Ueda et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- A phase II, open-label, extension study of long-term patisiran treatment in patients with hereditary transthyretin-mediated (hATTR) amyloidosis
- (2020) Teresa Coelho et al. Orphanet Journal of Rare Diseases
- Clinical characteristics and natural history of wild‐type transthyretin amyloid cardiomyopathy in Japan
- (2020) Toshihiro Yamada et al. ESC Heart Failure
- Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial ( ATTR‐ACT ) and long‐term extension study
- (2020) Thibaud Damy et al. EUROPEAN JOURNAL OF HEART FAILURE
- Neurofilament light chain (NfL) as a biomarker of hereditary transthyretin-mediated amyloidosis
- (2020) Simina Ticau et al. NEUROLOGY
- Abdominal fat pad biopsies exhibit good diagnostic accuracy in patients with suspected transthyretin amyloidosis
- (2020) Hedvig Paulsson Rokke et al. Orphanet Journal of Rare Diseases
- hATTR Pathology: Nerve Biopsy Results from Italian Referral Centers
- (2020) Marco Luigetti et al. Brain Sciences
- Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study
- (2020) David Adams et al. LANCET NEUROLOGY
- Recommendations for pre-symptomatic genetic testing for hereditary transthyretin amyloidosis in the era of effective therapy: a multicenter Italian consensus
- (2020) M. Grandis et al. Orphanet Journal of Rare Diseases
- Large normal alleles of ATXN2 decrease age-at-onset in TTR-FAP Val30Met patients
- (2019) Diana Santos et al. ANNALS OF NEUROLOGY
- Transthyretin Stabilization by AG10 in Symptomatic Transthyretin Amyloid Cardiomyopathy
- (2019) Daniel P. Judge et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Skin Nerve Pathology: Biomarkers of Premanifest and Manifest Amyloid Neuropathy
- (2019) Chi-Chao Chao et al. ANNALS OF NEUROLOGY
- Transthyretin deposition in the eye in the era of effective therapy for hereditary ATTRV30M amyloidosis
- (2019) Joel N. Buxbaum et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- Burden of Hereditary Transthyretin Amyloidosis on Quality of Life
- (2019) Aaron Yarlas et al. MUSCLE & NERVE
- Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease
- (2019) David Adams et al. Nature Reviews Neurology
- Extremely Early Onset Transthyretin Familial Amyloid Polyneuropathy with a Leu55Pro Mutation: A Pediatric Case Report and Literature Review
- (2019) Yun Jeong Lee et al. NEUROPEDIATRICS
- First‐in‐Human Study of AG10, a Novel, Oral, Specific, Selective, and Potent Transthyretin Stabilizer for the Treatment of Transthyretin Amyloidosis: A Phase 1 Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study in Healthy Adult Volunteers
- (2019) Jonathan C. Fox et al. Clinical Pharmacology in Drug Development
- Development of measures of polyneuropathy impairment in hATTR amyloidosis: From NIS to mNIS + 7
- (2019) P. James B. Dyck et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Cardiac denervation evidenced by MIBG occurs earlier than amyloid deposits detection by diphosphonate scintigraphy in TTR mutation carriers
- (2018) Eve Piekarski et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Biomarker definitions and their applications
- (2018) Robert M Califf EXPERIMENTAL BIOLOGY AND MEDICINE
- Estimating the global prevalence of transthyretin familial amyloid polyneuropathy
- (2018) Hartmut H. Schmidt et al. MUSCLE & NERVE
- Transthyretin amyloid polyneuropathies mimicking a demyelinating polyneuropathy
- (2018) Pierre Lozeron et al. NEUROLOGY
- Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
- (2018) David Adams et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
- (2018) Merrill D. Benson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm
- (2018) Yoshiki Sekijima et al. Orphanet Journal of Rare Diseases
- Clinical outcomes after preimplantation genetic diagnosis of patients with Corino de Andrade disease (familial amyloid polyneuropathy)
- (2018) Rita Lopes et al. REPRODUCTIVE BIOMEDICINE ONLINE
- Screening for Fabry disease and hereditary ATTR amyloidosis in idiopathic small fiber and mixed neuropathy
- (2018) Kristin Samuelsson et al. MUSCLE & NERVE
- Epidemiology of Transthyretin Familial Amyloid Polyneuropathy in Portugal: A Nationwide Study
- (2018) Mónica Inês et al. NEUROEPIDEMIOLOGY
- Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
- (2018) Mathew S. Maurer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Upper limb onset of hereditary transthyretin amyloidosis is common in non‐endemic areas
- (2018) M. Théaudin et al. EUROPEAN JOURNAL OF NEUROLOGY
- Transthyretin V122I (pV142I)* cardiac amyloidosis: an age-dependent autosomal dominant cardiomyopathy too common to be overlooked as a cause of significant heart disease in elderly African Americans
- (2017) Joel N. Buxbaum et al. GENETICS IN MEDICINE
- Age-dependent cognitive dysfunction in untreated hereditary transthyretin amyloidosis
- (2017) Ana Martins da Silva et al. JOURNAL OF NEUROLOGY
- mtDNA copy number associated with age of onset in familial amyloid polyneuropathy
- (2017) Diana Santos et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Diagnostic challenges in hereditary transthyretin amyloidosis with polyneuropathy: avoiding misdiagnosis of a treatable hereditary neuropathy
- (2017) Andrea Cortese et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Sural nerve injury in familial amyloid polyneuropathy
- (2017) Jennifer Kollmer et al. NEUROLOGY
- Nonbiopsy Diagnosis of Cardiac Transthyretin AmyloidosisCLINICAL PERSPECTIVE
- (2016) Julian D. Gillmore et al. CIRCULATION
- “Red-flag” symptom clusters in transthyretin familial amyloid polyneuropathy
- (2016) Isabel Conceição et al. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
- Cerebral amyloid angiopathy in posttransplant patients with hereditary ATTR amyloidosis
- (2016) Yoshiki Sekijima et al. NEUROLOGY
- Safety and efficacy of long-term diflunisal administration in hereditary transthyretin (ATTR) amyloidosis
- (2015) Yoshiki Sekijima et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- Genotype-phenotype correlation and course of transthyretin familial amyloid polyneuropathies in France
- (2015) Louise-Laure Mariani et al. ANNALS OF NEUROLOGY
- Liver Transplantation for Hereditary Transthyretin Amyloidosis
- (2015) Bo-Göran Ericzon et al. TRANSPLANTATION
- Repurposing Diflunisal for Familial Amyloid Polyneuropathy
- (2015) John L. Berk et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Online Registry for Mutations in Hereditary Amyloidosis Including Nomenclature Recommendations
- (2014) Dorota M. Rowczenio et al. HUMAN MUTATION
- Overcoming artefact: anticipation in 284 Portuguese kindreds with familial amyloid polyneuropathy (FAP) ATTRV30M
- (2013) C. Lemos et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Progression of transthyretin amyloid neuropathy after liver transplantation
- (2010) J. J. Liepnieks et al. NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now